Difference between revisions of "Breast cancer grading"
Jump to navigation
Jump to search
(8 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
The most common is the ''Nottingham system'', also known as ''Scarff-Bloom-Richardson''. | The most common is the ''Nottingham system'', also known as ''Scarff-Bloom-Richardson''. | ||
''Nottingham grade'' and ''Nottingham score'' redirect here. | |||
==Nottingham system== | ==Nottingham system== | ||
Line 14: | Line 16: | ||
#*Minimal <10% = 3. | #*Minimal <10% = 3. | ||
# Mitotic rate. | # Mitotic rate. | ||
#*0-5 mitosis/10 [[HPF]] (1.52 mm | #*0-5 mitosis/10 [[HPF]] (1.52 mm<sup>2</sup> --or-- 0.0152 mm<sup>2</sup> * 10) = 1. | ||
#*6-10 mitosis/10 HPF (1.52 mm | #*6-10 mitosis/10 HPF (1.52 mm<sup>2</sup>) = 2. | ||
#*>11 mitosis/10 HPF (1.52 mm | #*>11 mitosis/10 HPF (1.52 mm<sup>2</sup>) = 3. | ||
Mnemonic: ''TMN'' = tubule formation, mitotic rate, nuclear grade. | Mnemonic: ''TMN'' = tubule formation, mitotic rate, nuclear grade. | ||
Notes: | Notes: | ||
*Elston & Ellis devised the system that is used.<ref name= | *Elston & Ellis devised the system that is used.<ref name=pmid1757079>{{cite journal |author=Elston CW, Ellis IO |title=Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up |journal=Histopathology |volume=19 |issue=5 |pages=403–10 |year=1991 |month=November |pmid=1757079 |doi= |url=}}</ref> They also wrote a follow-up article in 2002.<ref name=pmid12405945>{{cite journal |author=Elston CW, Ellis IO |title=Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410 |journal=Histopathology |volume=41 |issue=3A |pages=151–2, discussion 152–3 |year=2002 |month=September |pmid=12405945 |doi= |url=}}</ref> | ||
==Note about mitosis counting== | ===Note about mitosis counting=== | ||
*One | *One really ought to adjust for the size of the field of view. | ||
*Most of | *Most of modern microscopes have an eye piece diameter of 22 mm. Therefore, the field diameter at 40x is approximately 22 mm / 40x ~= 0.55 mm and the field of view is pi/4*(0.55 mm)<sup>2</sup> = 0.2376 mm<sup>2</sup>. | ||
**Thus, on a | **Thus, on a typical modern microscope (with a FOV of 0.2376 mm<sup>2</sup>) one should sample 6 or 7 fields of view (FsOV). | ||
***Calculation: 1.52 mm | ***Calculation: 1.52 mm<sup>2</sup> (sampling area) / 0.2376 mm<sup>2</sup> (area / FOV ) = 6.40 FsOV. | ||
'''STATISTICAL NOTE''': | |||
Sampling 10 high power fields, where the field of view (FOV) is 0.152 mm<sup>2</sup>, is ''not'' the same as sampling ten fields, where the FOV is 0.312 mm<sup>2</sup>. It surprising that Elston & Ellis ignore the fact that "10 HPFs" on different microscopes represent different sample areas and that they do ''not'' standardize the sampling area. | |||
==Calculating Nottingham score== | ==Calculating Nottingham score== | ||
Line 37: | Line 40: | ||
Notes: | Notes: | ||
* | *Most tumours are grade II. | ||
*The mitotic score is | *The mitotic score is most often 1/3. | ||
*The nuclear score is rarely 1/3 -- even in the tubular subtype.<ref>MUA. 20 January 2009.</ref> | *The nuclear score is rarely 1/3 -- even in the tubular subtype.<ref>MUA. 20 January 2009.</ref> | ||
Line 44: | Line 47: | ||
*[[Invasive breast cancer]]. | *[[Invasive breast cancer]]. | ||
*[[Breast cancer staging]]. | *[[Breast cancer staging]]. | ||
*[[HPFitis]]. | |||
==References== | ==References== |
Latest revision as of 02:44, 30 November 2016
Breast cancer grading is useful prognosticator. It is done routinely on all invasive breast cancers.
The most common is the Nottingham system, also known as Scarff-Bloom-Richardson.
Nottingham grade and Nottingham score redirect here.
Nottingham system
Nottingham is based on:
- Nuclear grade.
- Small, regular (1.5-2x RBC dia.) = 1.
- Moderated variability = 2.
- Marked variation (>2.5x RBC dia.) = 3.
- Tubule formation.
- Majority of tumour - tubules >75% = 1.
- Moderate - 10% to 75% = 2.
- Minimal <10% = 3.
- Mitotic rate.
- 0-5 mitosis/10 HPF (1.52 mm2 --or-- 0.0152 mm2 * 10) = 1.
- 6-10 mitosis/10 HPF (1.52 mm2) = 2.
- >11 mitosis/10 HPF (1.52 mm2) = 3.
Mnemonic: TMN = tubule formation, mitotic rate, nuclear grade.
Notes:
Note about mitosis counting
- One really ought to adjust for the size of the field of view.
- Most of modern microscopes have an eye piece diameter of 22 mm. Therefore, the field diameter at 40x is approximately 22 mm / 40x ~= 0.55 mm and the field of view is pi/4*(0.55 mm)2 = 0.2376 mm2.
- Thus, on a typical modern microscope (with a FOV of 0.2376 mm2) one should sample 6 or 7 fields of view (FsOV).
- Calculation: 1.52 mm2 (sampling area) / 0.2376 mm2 (area / FOV ) = 6.40 FsOV.
- Thus, on a typical modern microscope (with a FOV of 0.2376 mm2) one should sample 6 or 7 fields of view (FsOV).
STATISTICAL NOTE: Sampling 10 high power fields, where the field of view (FOV) is 0.152 mm2, is not the same as sampling ten fields, where the FOV is 0.312 mm2. It surprising that Elston & Ellis ignore the fact that "10 HPFs" on different microscopes represent different sample areas and that they do not standardize the sampling area.
Calculating Nottingham score
- Grade I = 3-5 points.
- Grade II = 6-7 points.
- Grade III = 8-9 points.
Notes:
- Most tumours are grade II.
- The mitotic score is most often 1/3.
- The nuclear score is rarely 1/3 -- even in the tubular subtype.[3]
See also
References
- ↑ Elston CW, Ellis IO (November 1991). "Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up". Histopathology 19 (5): 403–10. PMID 1757079.
- ↑ Elston CW, Ellis IO (September 2002). "Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410". Histopathology 41 (3A): 151–2, discussion 152–3. PMID 12405945.
- ↑ MUA. 20 January 2009.